KRISTEN MULLEN: Open Payments
NPI 1770093833 · MC KEES ROCKS, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,455 in 67 payments from 15 companies in 2025. Trend: 2023 $2,272 · 2024 $2,296 · 2025 $1,455
Food & beverage: $1,389Education: $66
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $244 |
| Janssen Pharmaceuticals, Inc | 11 | $225 |
| Otsuka America Pharmaceutical, Inc. | 8 | $201 |
| Neurocrine BioSciences, Inc. | 8 | $188 |
| Teva Pharmaceuticals USA, Inc. | 5 | $134 |
| ABBVIE INC. | 7 | $119 |
| E.R. Squibb & Sons, L.L.C. | 3 | $70 |
| Axsome Therapeutics, Inc. | 4 | $68 |
| Lundbeck LLC | 3 | $52 |
| Alkermes, Inc. | 2 | $47 |
Products named: CAPLYTA, INGREZZA, SPRAVATO, VRAYLAR, ABILIFY ASIMTUFII, REXULTI, INVEGA SUSTENNA, COBENFY.
Industry payments across PA — which companies pay providers there.
